US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Spdr S&P Biotech Etf

149.58

-0.6500-0.43%

Volume:11.10M

Turnover:1.64B

Market Cap:9.99B

PE:8.21

High:149.69

Open:148.97

Low:146.01

Close:150.23

52wk High:169.89

52wk Low:103.43

Shares:66.78M

Float Shares:66.78M

Volume Ratio:1.09

T/O Rate:16.62%

Dividend:0.54

Dividend Rate:0.36%

EPS(TTM):18.23

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Starcoin Group Presses Ahead With Bond Restructuring as Trading Suspension Persists

Is Ping An Healthcare And Technology (SEHK:1833) Undervalued After Its GlobalCare Launch?

Simply Wall St.

Shanghai Henlius Stock And The Amberstone Licensing Deal Explained

Simply Wall St.

LIVE Markets-TD Cowen Says AI Promises Hospitals a Margin Cure

Pharming Group: Buy Rating Maintained and Strategy Intact Despite Surprise CEO Departure; Price Target Reaffirmed at $38

LIVE Markets-Cooler than Expected PCE Adds Some Steam to US Stock Futures

Health Care Select Sector SPDR: Pivot points

Legend Biotech Price Target Maintained with a $65.00/Share by HC Wainwright & Co.

3 Australian Biotech Stocks With Up To 77% Fair Value Upside

Simply Wall St.

Analysts Are Bullish on Top Healthcare Stocks: Abbott Laboratories (ABT), Tectonic Therapeutic (TECX)

Health Care Roundup: Market Talk

Yamashita Health Care Sees FY Net Y553.00m

Lonza Strengthens Board with Nomination of Biotech Veteran Pearl Huang

IHH Healthcare's Recent Weakness Likely Offers a Buying Opportunity

Veraxa Biotech Director Makes Bold Move With Fresh Insider Buy

Golden Globe Resources Sets Date and Digital Framework for 2026 AGM

Healthcare Stocks Declined as Consumer Confidence Slips

Health Care Roundup: Market Talk

Max Healthcare updates on adjourned NCLT case involving Kalinga Hospital subsidiary

Analyst Gil Blum Lifts Immix Biopharma Price Target to $30 on Strong NEXICART-2 Data and Accelerated Commercial Path

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/XBI/news?page=11"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"Spdr S&P Biotech Etf","latestPrice":149.58,"timestamp":1791488170503,"preClose":150.23,"halted":0,"volume":11099477,"delay":0,"changeRate":-0.004326699061438975,"floatShares":66775000,"shares":66775000,"eps":18.23,"marketStatus":"Trading","change":-0.65,"latestTime":"10-08 15:36:12 EDT","open":148.965,"high":149.69,"low":146.01,"amount":1640653320.5028899,"amplitude":0.024496,"askPrice":149.59,"askSize":725,"bidPrice":149.52,"bidSize":43,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791489600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":150.23,"sharesOutstanding":63325000,"nav":150.887016,"aum":10150924015.3,"dividendRate":0.003615,"bidAskSpread":0.000319,"preHourTrading":{"tag":"盘前","latestPrice":149.1,"preClose":150.23,"latestTime":"09:29 EDT","volume":9694,"amount":1448499.48538,"timestamp":1791466199999,"change":-1.13,"changeRate":-0.007522,"amplitude":0.00892},"postHourTrading":{"tag":"盘后","latestPrice":150.35,"preClose":150.23,"latestTime":"19:58 EDT","volume":167200,"amount":25204332.0509,"timestamp":1791417514777,"change":0.12,"changeRate":0.000799,"amplitude":0.004247},"volumeRatio":1.090597,"optionData":{"bulkOrders":[{"symbol":"XBI","call":false,"expireDate":1791518400000,"strike":"148.0","timestamp":1791472753100,"price":1.92,"volume":1692,"amount":324864,"type":"-"},{"symbol":"XBI","call":false,"expireDate":1791518400000,"strike":"155.0","timestamp":1791472753100,"price":8.07,"volume":1692,"amount":1365444,"type":"+"}]},"impliedVol":0.3315,"impliedVolPercentile":0.757},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":66775000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.090597,"shares":66775000,"dividePrice":0.5408,"high":149.69,"amplitude":0.024496,"preClose":150.23,"low":146.01,"week52Low":103.43,"pbRate":"--","week52High":169.89,"institutionHeld":0.8511,"latestPrice":149.58,"committee":-0.888021,"eps":18.23,"divideRate":0.003615,"volume":11099477,"delay":0,"ttmEps":18.23,"open":148.965,"prevYearClose":121.93,"prevWeekClose":154.43,"prevMonthClose":157.68,"prevQuarterClose":157.68,"fiveDayClose":154.51,"twentyDayClose":156.82,"sixtyDayClose":156.22},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"},{"executeDate":"2018-03-16","recordDate":"2018-03-19","paymentDate":"2018-03-21","value":0.059081,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:11,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671853217","title":"Starcoin Group Presses Ahead With Bond Restructuring as Trading Suspension Persists","url":"https://stock-news.laohu8.com/highlight/detail?id=2671853217","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671853217?lang=en_us&edition=fundamental","pubTime":"2026-09-30 23:09","pubTimestamp":1790780987,"startTime":"0","endTime":"0","summary":"Innovative Pharmaceutical Biotech ( ($HK:0399) ) has provided an announcement. Starcoin Group Limited has provided a new quarterly update on its ef...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/starcoin-group-presses-ahead-with-bond-restructuring-as-trading-suspension-persists?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/starcoin-group-presses-ahead-with-bond-restructuring-as-trading-suspension-persists?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["US3Y.BOND","US10Y.BOND","US2Y.BOND","US5Y.BOND","XBI","BK4585","TLTW","TMF","US7Y.BOND","TLT","US12M.BOND","BK4588","US6M.BOND","BK4581","US30Y.BOND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672873841","title":"Is Ping An Healthcare And Technology (SEHK:1833) Undervalued After Its GlobalCare Launch?","url":"https://stock-news.laohu8.com/highlight/detail?id=2672873841","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672873841?lang=en_us&edition=fundamental","pubTime":"2026-09-30 22:24","pubTimestamp":1790778257,"startTime":"0","endTime":"0","summary":"Ping An Healthcare and Technology (SEHK:1833) has put its new Ping An GlobalCare platform in the spotlight by launching a trial in Shenzhen that combines AI-driven real-time medical translation with a fully coordinated online and offline care journey.\nAgainst this product launch, Ping An Healthcare and Technology’s recent share price return has been mixed, with a 7 day gain of 4.02% but a 90 day decline of 10.25% and a year to date fall of 56.48% at a HK$6.345 close. Over a longer horizon,...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/5021000-choice2-card/1789013271957","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/5021000-choice2-card/1789013271957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-1833/ping-an-healthcare-and-technology-shares/news/is-ping-an-healthcare-and-technology-sehk1833-undervalued-af","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-1833/ping-an-healthcare-and-technology-shares/news/is-ping-an-healthcare-and-technology-sehk1833-undervalued-af","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1219","BK4137","LU0029874061.USD","BK4588","BK4581","LABU","BK1142","BK1515","BK4585","HCSG","BK1247","BK1615","01833","LU0128526141.USD","XLV","BK1571","DCF","BK1617","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672426738","title":"Shanghai Henlius Stock And The Amberstone Licensing Deal Explained","url":"https://stock-news.laohu8.com/highlight/detail?id=2672426738","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672426738?lang=en_us&edition=fundamental","pubTime":"2026-09-30 22:21","pubTimestamp":1790778087,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech entered a collaboration and license agreement with Amberstone Biosciences, securing exclusive rights to research, develop, manufacture, and commercialize products using Amberstone technology in its territory, in return for a US$4 million upfront fee, up to US$232.16 million in R&D and regulatory milestones, up to US$652 million in sales milestones, and single digit royalty payments.\nThis structure ties Shanghai Henlius Biotech’s future cash commitments directly to...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2696/shanghai-henlius-biotech-shares/news/shanghai-henlius-stock-and-the-amberstone-licensing-deal-exp","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2696/shanghai-henlius-biotech-shares/news/shanghai-henlius-stock-and-the-amberstone-licensing-deal-exp","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02696","HK0000320223.HKD","HK0000165453.HKD","HK0000306685.HKD","XBI","HK0000306701.USD","BK1161","BK4588","BK4585","HK0000320264.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671207594","title":"LIVE Markets-TD Cowen Says AI Promises Hospitals a Margin Cure","url":"https://stock-news.laohu8.com/highlight/detail?id=2671207594","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671207594?lang=en_us&edition=fundamental","pubTime":"2026-09-30 21:18","pubTimestamp":1790774293,"startTime":"0","endTime":"0","summary":"CLICK HEREWHAT TO THINK ABOUT IN Q4CLICK HERESTOCKS POISED FOR NEXT LEG HIGHER... IF OIL DROPSCLICK HERESTOXX SET FOR MONTHLY FALL, BUT A STEADY QUARTERCLICK HEREBEFORE THE BELL: SET TO END THE MONTH ON A HIGH NOTECLICK HEREA CRUEL QUARTER FOR BONDSCLICK HERE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nL6N45M0UY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0980610538.SGD","LU0029864427.USD","LU0310799852.SGD","BK4585","LU0985489474.SGD","SG9999014039.USD","XBI","LU0187121727.USD","LU2244417387.USD","LU0310800379.SGD","HCA","IE00B3S45H60.SGD","LU0203347892.USD","LU0868494617.USD","BK4588","LU1084165304.USD","BK4581","LU1201861249.SGD","LU0130103400.USD","LU0708994859.HKD","LU1150488218.USD","LU1489326972.SGD","LU1261432733.SGD","IE00B775SV38.USD","LU1201861165.SGD","LU0211328371.USD","LU0648000940.SGD","LU1150488135.SGD","SG9999014005.SGD","IHF","LU0114720955.EUR","LABU","LU0882574055.USD","LU0878866978.SGD","BK4504","LU0433182093.SGD","UHS","LU1267930490.SGD","BK4185","LU1267930573.SGD","SG9999014021.USD","XLV","LU0130102774.USD","THC","LU0128525929.USD","LU0211327993.USD","LU0203345920.USD","LU1119994496.HKD","LU0068578508.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671207668","title":"Pharming Group: Buy Rating Maintained and Strategy Intact Despite Surprise CEO Departure; Price Target Reaffirmed at $38","url":"https://stock-news.laohu8.com/highlight/detail?id=2671207668","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671207668?lang=en_us&edition=fundamental","pubTime":"2026-09-30 21:15","pubTimestamp":1790774145,"startTime":"0","endTime":"0","summary":"Pharming Group, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Whitney Ijem from Canaccord Genuity mainta...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/pharming-group-buy-rating-maintained-and-strategy-intact-despite-surprise-ceo-departure-price-target-reaffirmed-at-38-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/pharming-group-buy-rating-maintained-and-strategy-intact-despite-surprise-ceo-departure-price-target-reaffirmed-at-38-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","LABU","XBI","BK4585","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671202023","title":"LIVE Markets-Cooler than Expected PCE Adds Some Steam to US Stock Futures","url":"https://stock-news.laohu8.com/highlight/detail?id=2671202023","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671202023?lang=en_us&edition=fundamental","pubTime":"2026-09-30 21:09","pubTimestamp":1790773775,"startTime":"0","endTime":"0","summary":"CLICK HEREWHAT TO THINK ABOUT IN Q4CLICK HERESTOCKS POISED FOR NEXT LEG HIGHER... IF OIL DROPSCLICK HERESTOXX SET FOR MONTHLY FALL, BUT A STEADY QUARTERCLICK HEREBEFORE THE BELL: SET TO END THE MONTH ON A HIGH NOTECLICK HEREA CRUEL QUARTER FOR BONDSCLICK HERELMData093020","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nL6N45M0NX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","XLY","KRE","XLK","XBI","XLV","SOXQ","BK4581","XLB","LABU","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671047562","title":"Health Care Select Sector SPDR: Pivot points","url":"https://stock-news.laohu8.com/highlight/detail?id=2671047562","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671047562?lang=en_us&edition=fundamental","pubTime":"2026-09-30 20:37","pubTimestamp":1790771845,"startTime":"0","endTime":"0","summary":"The following are the pivot points for the Health Care Select Sector SPDR (XLV). Pivot High: $172.50, Pivot Low: $169.78. These were calculated usi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-153?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-153?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4581","BK4585","BK4588","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671058052","title":"Legend Biotech Price Target Maintained with a $65.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2671058052","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671058052?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:37","pubTimestamp":1790764620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LEGN/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","LEGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672738443","title":"3 Australian Biotech Stocks With Up To 77% Fair Value Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2672738443","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672738443?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:20","pubTimestamp":1790763656,"startTime":"0","endTime":"0","summary":"Australia’s inflation rate sitting at 4% and interest rates at a 15 year high of 4.6% are squeezing many growth stories. Yet that pressure also pushes investors toward companies with solid balance sheets and clear funding runways. That matters for Australian biotechnology stocks, where capital access can make or break a breakthrough. This article highlights three listed biotech opportunities screened for financial resilience and reasonable value.\nThe three biotech stocks covered below are a...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice1-card/1788949577743","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice1-card/1788949577743"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-vls/vita-life-sciences-shares/news/3-australian-biotech-stocks-with-up-to-77-fair-value-upside","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-vls/vita-life-sciences-shares/news/3-australian-biotech-stocks-with-up-to-77-fair-value-upside","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SLF.AU","BEAR.AU","OZR.AU","STW.AU","ZYAU.AU","XAO.AU","OZF.AU","GIVE.AU","IIGF.AU","NVIB","BK7508","VAS.AU","IOZ.AU","XBI","XKO.AU","VLS.AU","BK4581","GEAR.AU","IMLC.AU","VAP.AU","E200.AU","BBOZ.AU","QRE.AU","MYX.AU","BK4585","BK7096","XBIX","EIGA.AU","CUV.AU","BK4588","DACE.AU","BK7067","IISV.AU","XJO.AU","QFN.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671724342","title":"Analysts Are Bullish on Top Healthcare Stocks: Abbott Laboratories (ABT), Tectonic Therapeutic (TECX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671724342","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671724342?lang=en_us&edition=fundamental","pubTime":"2026-09-30 16:50","pubTimestamp":1790758222,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Abbott Laboratories (ABT), Tectonic Therapeutic (TEC...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-abbott-laboratories-abt-tectonic-therapeutic-tecx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-abbott-laboratories-abt-tectonic-therapeutic-tecx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFTCPJ56.SGD","LU1023059063.AUD","LU0170899867.USD","LU0058720904.USD","LU2468319806.SGD","BK4533","IE0009355771.USD","LU2089984988.USD","LU1670628061.USD","TMED","LU0266013472.USD","XBI","LU0432979614.USD","SG9999002232.USD","XLV","LU1057294990.SGD","HCSG","LU0868494617.USD","SGXZ23171101.USD","BK4585","LU1721429741.USD","LU1721429402.USD","BK4581","LU0208291251.USD","LU2133065610.SGD","IE0002141913.USD","PJP","TECX","LU1061106388.HKD","LU0289739699.SGD","IE00B2B36J28.USD","LU0114720955.EUR","LU0122379950.USD","LU0320765489.SGD","LABU","LU0128526141.USD","LU1914381329.SGD","LU2112291526.USD","LU1989763690.USD","BK4139","LU0211331839.USD","ABT","IHI","SG9999004303.SGD","LU0882574055.USD","BK4588","BK4137","BK4568","LU2237957811.SGD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671027487","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2671027487","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671027487?lang=en_us&edition=fundamental","pubTime":"2026-09-30 16:20","pubTimestamp":1790756400,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0749 GMT - Fresenius investors might have overreacted to news th","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","XBI","BK4585","VOTE","BK4588","DECU","BK4581","PMDE","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671275727","title":"Yamashita Health Care Sees FY Net Y553.00m","url":"https://stock-news.laohu8.com/highlight/detail?id=2671275727","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671275727?lang=en_us&edition=fundamental","pubTime":"2026-09-30 15:00","pubTimestamp":1790751600,"startTime":"0","endTime":"0","summary":"Yamashita Health Care Holdings Inc. also released the following forecasts:. Results are based on Japanese accounting standards.This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4581","XLV","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671278331","title":"Lonza Strengthens Board with Nomination of Biotech Veteran Pearl Huang","url":"https://stock-news.laohu8.com/highlight/detail?id=2671278331","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671278331?lang=en_us&edition=fundamental","pubTime":"2026-09-30 13:32","pubTimestamp":1790746351,"startTime":"0","endTime":"0","summary":"The latest update is out from Lonza Group Ltd ( ($CH:LONN) ). Lonza has nominated pharmaceutical and biotechnology veteran Pearl Huang as an indepe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lonza-strengthens-board-with-nomination-of-biotech-veteran-pearl-huang?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lonza-strengthens-board-with-nomination-of-biotech-veteran-pearl-huang?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","XT","FWD","LNGR","XBI","BK4585","BK4588","BBP","FHLC","JDOC","DARP","BK4581","IBB","IEIH","SYNB","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671221962","title":"IHH Healthcare's Recent Weakness Likely Offers a Buying Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2671221962","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671221962?lang=en_us&edition=fundamental","pubTime":"2026-09-30 10:11","pubTimestamp":1790734260,"startTime":"0","endTime":"0","summary":"0211 GMT - IHH Healthcare's recent share price weakness is likely an enhanced buying opportunity, with Fortis-related litigation concerns expected to have limited impact on operations, says Citi analyst Megat Fais in a note. IHH says it isn't subject to financial claims in the dispute involving Daiichi Sankyo and former Fortis promoters. IHH's India plans remain on track to reach 10,000 beds target by 2030-2031, while Singapore's recovery is expected to continue, he reckons. Malaysia should see growth from selective bed additions and medical tourism, while Turkey's strong demand and international patient flows are expected to continue, he adds. Citi keeps a buy rating and its target price at 10.40 ringgit. Shares are 0.1% higher at 7.88 ringgit.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0029874061.USD","LU0128526141.USD","BK4581","BK4137","XLV","BK4585","HCSG","DSNKY","BK4007","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671412221","title":"Veraxa Biotech Director Makes Bold Move With Fresh Insider Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2671412221","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671412221?lang=en_us&edition=fundamental","pubTime":"2026-09-30 10:01","pubTimestamp":1790733716,"startTime":"0","endTime":"0","summary":"New insider activity at Veraxa Biotech ( ($VRXA) ) has taken place on September 29, 2026. Director Warren Hosseinion has recently strengthened his ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/veraxa-biotech-director-makes-bold-move-with-fresh-insider-buy-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/veraxa-biotech-director-makes-bold-move-with-fresh-insider-buy-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XBI","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671044225","title":"Golden Globe Resources Sets Date and Digital Framework for 2026 AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2671044225","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671044225?lang=en_us&edition=fundamental","pubTime":"2026-09-30 08:23","pubTimestamp":1790727806,"startTime":"0","endTime":"0","summary":"Reckon Health Care Holdings Ltd ( ($AU:GGR) ) has shared an announcement. Golden Globe Resources Limited has convened its 2026 Annual General Meeti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/golden-globe-resources-sets-date-and-digital-framework-for-2026-agm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/golden-globe-resources-sets-date-and-digital-framework-for-2026-agm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","XLV","LABU","BK4588","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671247293","title":"Healthcare Stocks Declined as Consumer Confidence Slips","url":"https://stock-news.laohu8.com/highlight/detail?id=2671247293","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671247293?lang=en_us&edition=fundamental","pubTime":"2026-09-30 04:58","pubTimestamp":1790715480,"startTime":"0","endTime":"0","summary":"On a losing day in Wall Street, the healthcare industry was no exemption. Stocks fell amid a surprising decline in the Conference Board Consumer Confidence Index.UniQure slid after patients treated with its Huntington's disease drug in a recent study no longer showed a statistically significant slowdown in disease-induced decline after four years. At four years, the study's primary endpoint--composite Unified Huntington's Disease Rating Scale --showed a 44% slowing of disease progression compared with an external control, but the data did not reach statistical significance, the company said.Novo Nordisk has signed a licensing deal for a weight-loss treatment being developed by Hengrui Pharma that could be worth up to $2.6 billion. The Danish drugmaker will pay China-based Hengrui $300 million upfront, with the rest of the potential deal value tied to milestones. Novo will obtain exclusive rights to develop, manufacture and commercialize HRS-1596 globally, excluding mainland China, Hong","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LABU","LU0128526141.USD","BK4581","BK4588","LU0029874061.USD","HCSG","XBI","BK4137","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671247428","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2671247428","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671247428?lang=en_us&edition=fundamental","pubTime":"2026-09-30 04:50","pubTimestamp":1790715000,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.1019 ET - Sterling shows little reaction after U.K. Prime Minist","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","BK4581","BK4585","XLV","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671241431","title":"Max Healthcare updates on adjourned NCLT case involving Kalinga Hospital subsidiary","url":"https://stock-news.laohu8.com/highlight/detail?id=2671241431","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671241431?lang=en_us&edition=fundamental","pubTime":"2026-09-30 02:03","pubTimestamp":1790705014,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Max Healthcare Institute Ltd ( ($IN:MAXHEALTH) ). Max Healthcare Institute Ltd has updated exchanges on ongoing...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/max-healthcare-updates-on-adjourned-nclt-case-involving-kalinga-hospital-subsidiary?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/max-healthcare-updates-on-adjourned-nclt-case-involving-kalinga-hospital-subsidiary?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","XBI","HCSG","LABU","LU0029874061.USD","BK4137","XLV","BK4581","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671246794","title":"Analyst Gil Blum Lifts Immix Biopharma Price Target to $30 on Strong NEXICART-2 Data and Accelerated Commercial Path","url":"https://stock-news.laohu8.com/highlight/detail?id=2671246794","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671246794?lang=en_us&edition=fundamental","pubTime":"2026-09-30 00:55","pubTimestamp":1790700918,"startTime":"0","endTime":"0","summary":"Immix Biopharma, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Gil Blum from Needham reiterated a Buy rating...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-gil-blum-lifts-immix-biopharma-price-target-to-30-on-strong-nexicart-2-data-and-accelerated-commercial-path-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-gil-blum-lifts-immix-biopharma-price-target-to-30-on-strong-nexicart-2-data-and-accelerated-commercial-path-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","XLV","LABU","BK4581","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":11,"totalSize":330,"code":"91000000","status":"200"}]}}